| BMI category | Beta (95 % CI) | p-value |
---|---|---|---|
LBPa | Lean (reference) | – |  |
 | Underweight | −4.92 (−18.1; 8.27) | 0.45 |
 | Overweight | −3.90 (−7.4;−0.41) | 0.03 |
 | Obesity class I | −0.83 (−6.1; 4.46) | 0.76 |
 | Obesity class II–III | 3.43 (−3.81; 10.68) | 0.35 |
 | ODI baseline | 0.59 (0.49; 0.69) | <0.001 |
 | FAB-P high | 7.76 (4.39; 11.13) | <0.001 |
 | FAB-W high | −0.82 (−7.1; 5.4) | 0.79 |
 | FAB-W high NA | 2.42 (−2.69)7.53) | 0.35 |
 | No relationship | 3.03 (−0.43; 6.49) | 0.09 |
 | Work-related RF | 3.03 (−2.25; 8.32) | 0.25 |
 | Chronic pain | 4.49 (0.34; 8.64) | 0.03 |
 | Treatment duration | 0.04 (−0.02; 0.09) | 0.16 |
NPa | Lean (reference) | – |  |
 | Underweight | −0.23 (−6.58; 6.12) | 0.94 |
 | Overweight | 0.91 (−2.23; 4.05) | 0.57 |
 | Obesity class I | −0.46 (−5.39; 4.48) | 0.85 |
 | Obesity class II–III | −4.65 (−11.98; 2.69) | 0.21 |
 | NDI baseline | 0.61 (0.43; 0.78) | <0.001 |
 | Work-related RF | 4.07 (−0.35; 8.48) | 0.07 |
 | Treatment duration | 0.03 (−0.02; 0.08) | 0.25 |